Conclusions: Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

Tas kā es interpretēju savai publikai ir mana darīšana un, acīmredzot, tava problēma.

Joprojām nav skaidrs kā manis prezentētais neatspēko "Visi (mediķi, zinātnieki) saka, ka potēšanās ir vienīgais risinājums."